ReviewFrontiers in medicine2023

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition.

Dionysis Nikolopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.